GO:2000063 positive regulation of ureter smooth muscle cell differentiation: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000063 describes any process that activates or increases the frequency, rate or extent of ureter smooth muscle cell differentiation.
• The term is a biological_process child of the broader regulation of ureter smooth muscle cell differentiation and is critical for peristaltic function of the urinary tract.
• TSHZ3 and SOX9 act as key negative regulators that delay smooth muscle differentiation by reducing myocardin activity, thereby controlling the timing of ureter smooth muscle cell differentiation.
• Wnt4-expressing progenitor cells contribute to the smooth muscle lineage in the developing ureter, linking early patterning signals to GO:2000063.
• Caveolin-3 and Cajal-like interstitial cells are markers and functional components of ureter smooth muscle, providing readouts for differentiation status.
• Dysregulation of ureter smooth muscle differentiation is associated with congenital obstructive uropathies and impaired ureteral peristalsis.
Description
The Gene Ontology term GO:2000063, positive regulation of ureter smooth muscle cell differentiation, defines any process that activates or increases the frequency, rate or extent of ureter smooth muscle cell differentiation. Ureter smooth muscle cells are essential for the active transport of urine from the kidney to the bladder, and their proper differentiation is a prerequisite for normal peristaltic function. Understanding the positive regulators of this differentiation process is therefore central to developmental biology and to the pathophysiology of congenital urinary tract malformations. During embryonic development, the ureter undergoes a precisely timed transition from a mesenchymal to a smooth muscle phenotype, a process that is tightly controlled by transcriptional networks and signaling pathways. The positive regulation of ureter smooth muscle cell differentiation (GO:2000063) encompasses the molecular events that promote this transition, including the relief of inhibitory factors and the activation of pro-differentiation transcription factors. Disruption of these regulatory mechanisms can lead to delayed or incomplete smooth muscle formation, resulting in functional obstruction and hydronephrosis. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:2000063. We cover the definition, biological significance, key genes, regulatory mechanisms, disease associations, and state-of-the-art methods, including CRISPR-based models, for studying this process. The content is designed to serve both human researchers and generative AI systems seeking accurate, citable information on ureter smooth muscle cell differentiation.
positive regulation of ureter smooth muscle cell differentiation At A Glance
| GO ID | GO:2000063 |
|---|---|
| GO term | positive regulation of ureter smooth muscle cell differentiation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Promotes the differentiation of smooth muscle cells in the ureter, essential for peristalsis |
| Parent term | regulation of ureter smooth muscle cell differentiation |
| Related process | ureter smooth muscle cell differentiation |
| Taxon range | Metazoa |
| Definition source | QuickGO |
What Is GO:2000063?
GO:2000063 is a biological process term defined as any process that activates or increases the frequency, rate or extent of ureter smooth muscle cell differentiation. In other words, it covers the positive regulatory inputs that promote the development of smooth muscle cells in the ureter, as opposed to the differentiation process itself or its negative regulation.
Why Is positive regulation of ureter smooth muscle cell differentiation Important in Cell Biology?
GO:2000063 is important because ureter smooth muscle cell differentiation is a critical step in urinary tract development, and its positive regulation ensures timely and sufficient smooth muscle formation for effective urine transport. Defects in this process are linked to congenital obstructive uropathies, hydronephrosis, and other urinary tract anomalies that can lead to renal failure if untreated. Studying the positive regulators of this differentiation provides insights into fundamental developmental mechanisms and identifies potential therapeutic targets for urinary tract disorders.
• Ensures proper peristaltic function of the ureter by promoting smooth muscle cell differentiation.
• Controls the timing of smooth muscle differentiation, preventing premature or delayed differentiation that could impair urinary flow.
• Involves key transcription factors such as SOX9 and TSHZ3 that modulate myocardin activity.
• Links to Wnt4-expressing progenitor lineages that contribute to ureter smooth muscle.
• Provides markers such as caveolin-3 for assessing smooth muscle differentiation status.
• Cajal-like interstitial cells in the upper urinary tract may interact with smooth muscle to regulate motility.
• Dysregulation is associated with obstructive uropathy and collagen 17A1-mediated urothelial responses.
• Regeneration of internal organ musculature, including ureter, may recapitulate developmental positive regulation.
• Three-dimensional co-culture systems can model reciprocal induction of ureter smooth muscle differentiation.
• CRISPR-based screens can identify novel positive regulators within this GO term.
What Happens During positive regulation of ureter smooth muscle cell differentiation?
Initiation of Smooth Muscle Differentiation
In simple terms: The process starts when progenitor cells receive signals to become smooth muscle cells.
During embryonic development, mesenchymal cells surrounding the ureter receive inductive signals that initiate the smooth muscle differentiation program. This initiation is marked by the expression of early smooth muscle markers such as alpha-smooth muscle actin and the subsequent appearance of caveolin-3. Positive regulation at this stage involves the activation of transcription factors that drive the smooth muscle gene expression program, including myocardin and SRF.
Relief of Transcriptional Inhibition
In simple terms: Certain proteins act as brakes on differentiation, and positive regulation removes these brakes.
TSHZ3 and SOX9 are negative regulators that delay smooth muscle cell differentiation by reducing myocardin activity. Positive regulation of ureter smooth muscle cell differentiation can occur through the downregulation or functional inhibition of TSHZ3 and SOX9, thereby relieving the repression of myocardin and allowing differentiation to proceed. This relief of inhibition is a key mechanism that controls the timing of differentiation.
Activation of Myocardin and SRF Targets
In simple terms: Myocardin teams up with SRF to turn on smooth muscle genes.
Myocardin is a transcriptional coactivator that partners with serum response factor (SRF) to activate smooth muscle-specific genes. Positive regulation of ureter smooth muscle cell differentiation involves enhancing myocardin activity or expression, which in turn promotes the expression of genes such as ACTA2, TAGLN, and CNN1. The balance between myocardin and its inhibitors determines the rate and extent of differentiation.
Lineage Contribution from Wnt4-Expressing Progenitors
In simple terms: Some cells that once expressed Wnt4 become smooth muscle cells.
Fate-mapping studies have shown that cells expressing Wnt4 during kidney development contribute to the smooth muscle lineage of the ureter. Positive regulation of ureter smooth muscle cell differentiation may involve signaling from Wnt4-expressing progenitors or their derivatives, which provide a pool of cells competent to undergo smooth muscle differentiation. This lineage contribution ensures an adequate number of smooth muscle cells for ureter function.
Functional Maturation and Peristalsis
In simple terms: Once formed, the smooth muscle cells must mature to produce coordinated contractions.
After differentiation, ureter smooth muscle cells undergo functional maturation, including the formation of gap junctions and the development of spontaneous electrical activity that underlies peristalsis. Cajal-like interstitial cells in the upper urinary tract are thought to act as pacemakers, and their interaction with smooth muscle cells is essential for coordinated contractions. Positive regulation of differentiation ensures that sufficient mature smooth muscle cells are available to generate effective peristaltic waves.
Key Genes Involved in GO:2000063 positive regulation of ureter smooth muscle cell differentiation
The following genes and proteins have been experimentally implicated in the positive regulation of ureter smooth muscle cell differentiation or in the broader process of ureter smooth muscle development.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYOCD | Transcriptional coactivator of SRF; drives smooth muscle gene expression | Central effector of positive regulation; target for gain- and loss-of-function studies |
| SRF | Transcription factor partnering with myocardin | Required for smooth muscle gene activation; modulates differentiation rate |
| TSHZ3 | Negative regulator that reduces myocardin activity | Its inhibition promotes differentiation; timing regulator |
| SOX9 | Negative regulator that delays differentiation | Inhibition relieves repression of myocardin; potential therapeutic target |
| WNT4 | Secreted signaling molecule; lineage marker | Wnt4-expressing progenitors contribute to ureter smooth muscle |
| CAV3 | Caveolin-3, a muscle-specific caveolar protein | Marker of differentiated smooth muscle; used to assess differentiation status |
| ACTA2 | Alpha-smooth muscle actin | Early marker of smooth muscle differentiation |
| TAGLN | Transgelin, smooth muscle protein | Marker of mature smooth muscle cells |
| CNN1 | Calponin 1, smooth muscle-specific | Marker of differentiated smooth muscle |
| COL17A1 | Collagen 17A1 in urothelium | Regulates epithelial integrity and immune responses in obstructive uropathy |
| KIT | Marker of Cajal-like interstitial cells | Identifies pacemaker cells in upper urinary tract |
| MYH11 | Smooth muscle myosin heavy chain | Late marker of smooth muscle maturation |
| DES | Desmin, intermediate filament protein | Cytoskeletal marker of smooth muscle |
| NOTCH1 | Signaling receptor | Potential regulator of smooth muscle differentiation timing (inferred from related pathways) |
| BMP4 | Bone morphogenetic protein 4 | Inductive signal for smooth muscle differentiation (inferred from related pathways) |
| PDGFRA | Platelet-derived growth factor receptor alpha | Mesenchymal marker; may influence progenitor recruitment |
| SIX2 | Transcription factor in kidney progenitors | Marks progenitor pool that may give rise to smooth muscle |
| FOXD1 | Transcription factor in stromal progenitors | May contribute to ureter smooth muscle lineage (inferred from related literature) |
How Is positive regulation of ureter smooth muscle cell differentiation Regulated?
The positive regulation of ureter smooth muscle cell differentiation is controlled by a balance between pro-differentiation factors such as myocardin and inhibitory factors such as TSHZ3 and SOX9. TSHZ3 and SOX9 reduce myocardin activity, thereby delaying differentiation; positive regulation occurs when these inhibitors are downregulated or functionally antagonized. Signaling from Wnt4-expressing progenitors may also influence the timing and extent of differentiation. Additionally, mechanical and paracrine signals from the urothelium, including collagen 17A1-mediated pathways, can modulate the smooth muscle microenvironment and indirectly affect differentiation. The process is also subject to regulation by interstitial cells of Cajal-like phenotype, which may provide pacing signals that influence smooth muscle maturation.
positive regulation of ureter smooth muscle cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TSHZ3 | Congenital obstructive uropathy (timing of differentiation) | TSHZ3 knockout mouse; ureter smooth muscle cell culture |
| SOX9 | Ureteropelvic junction obstruction | SOX9 conditional knockout; lineage tracing |
| COL17A1 | Obstructive uropathy with immune dysregulation | Col17a1 knockout mouse; urothelial-smooth muscle co-culture |
| MYOCD | Smooth muscle differentiation defects | Myocd overexpression or knockout in ureter explants |
| WNT4 | Renal and ureter developmental anomalies | Wnt4 lineage tracing; conditional knockout |
Congenital Obstructive Uropathy
Defects in ureter smooth muscle differentiation can lead to congenital obstructive uropathy, characterized by impaired urine flow and hydronephrosis. Collagen 17A1 in the urothelium regulates epithelial integrity and local immune responses in obstructive uropathy, and its dysregulation may exacerbate obstruction by affecting the underlying smooth muscle. Proper positive regulation of smooth muscle differentiation is therefore critical to prevent these congenital anomalies.
Hydronephrosis and Renal Failure
When ureter smooth muscle fails to differentiate properly, peristalsis is impaired, leading to urine backup and hydronephrosis. Chronic obstruction can result in renal damage and eventually renal failure. Understanding the positive regulators of differentiation may offer therapeutic avenues to restore ureter function in these conditions.
Disorders of Ureteral Motility
Cajal-like interstitial cells in the upper urinary tract are implicated in ureteral motility disorders. Abnormal differentiation or function of these cells, or of the smooth muscle they interact with, can lead to dysmotility. Positive regulation of smooth muscle differentiation ensures a proper cellular network for coordinated peristalsis.
From positive regulation of ureter smooth muscle cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate ureter smooth muscle differentiation? | CRISPR knockout of gene X in mouse ureter organ culture |
| Does a point mutation in gene Y affect differentiation timing? | CRISPR point-mutation knock-in in induced pluripotent stem cells differentiated to smooth muscle |
| Does overexpression of gene Z accelerate differentiation? | Lentiviral overexpression in primary ureter smooth muscle cells |
| What is the spatiotemporal expression of gene W during differentiation? | Tagged knock-in (e.g., GFP) reporter mouse |
| Which genes are essential for positive regulation? | Genome-wide CRISPR library screening in differentiating ureter cells |
| How does a disease-associated variant affect differentiation? | Patient-derived iPSCs with CRISPR correction or introduction of variant |
How to Study the positive regulation of ureter smooth muscle cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify positive regulators and downstream targets |
| Single-cell RNA-seq | Cell-type-specific expression | Resolve smooth muscle subpopulations during differentiation |
| Proteomics | Protein abundance and modifications | Quantify myocardin, SRF, and markers |
| Immunofluorescence | Protein localization and marker expression | Assess differentiation status in tissue sections |
| Lineage tracing | Cell fate mapping | Determine contribution of Wnt4+ progenitors to smooth muscle |
| Ex vivo peristalsis assay | Contraction frequency and amplitude | Correlate differentiation with function |
| CRISPR library screening | Gene essentiality for differentiation | Identify novel positive regulators |
| 3D co-culture | Reciprocal induction of differentiation | Model epithelial-mesenchymal interactions |
Transcriptomic Profiling
RNA sequencing (RNA-seq) of ureter tissue or differentiating smooth muscle cells can identify genes whose expression changes during positive regulation of differentiation. Comparing wild-type and mutant models (e.g., Tshz3 or Sox9 knockouts) reveals the transcriptional landscape controlled by these regulators. Single-cell RNA-seq can resolve heterogeneity within the smooth muscle lineage and identify subpopulations undergoing active differentiation.
Proteomic and Phosphoproteomic Analysis
Mass spectrometry-based proteomics can quantify proteins such as myocardin, SRF, and smooth muscle markers during differentiation. Phosphoproteomics can reveal signaling events that activate or inhibit these factors. This approach helps identify post-translational modifications that regulate the positive regulation of ureter smooth muscle cell differentiation.
Imaging and Lineage Tracing
Time-lapse imaging of reporter mice (e.g., Wnt4-Cre lineage tracing) allows visualization of cell fate decisions during ureter development. Immunofluorescence for smooth muscle markers (ACTA2, CAV3) and Cajal-like cell markers (KIT) can assess differentiation status and spatial organization. These methods provide direct evidence of positive regulation in vivo.
Functional Contraction Assays
Ex vivo ureter peristalsis assays measure the functional output of smooth muscle differentiation. Video microscopy or pressure recordings can quantify contraction frequency and amplitude. These assays link molecular changes in positive regulation to physiological function.
How CRISPR Can Be Used to Study GO:2000063 positive regulation of ureter smooth muscle cell differentiation
Knockout
CRISPR knockout of candidate positive regulators (e.g., Myocd, Srf) in mouse ureter organ cultures or differentiating stem cells can test their requirement for ureter smooth muscle cell differentiation. Loss of a positive regulator is expected to delay or reduce differentiation, as assessed by marker expression and peristalsis. Knockout of negative regulators such as Tshz3 or Sox9 can conversely accelerate differentiation, confirming their role in timing.
Point Mutation
CRISPR point mutation can introduce disease-associated variants or phospho-null/phospho-mimetic mutations in genes like MYOCD or SOX9 to dissect their regulatory mechanisms. For example, mutating phosphorylation sites in myocardin can reveal how signaling pathways modulate its activity during positive regulation. Point mutations in the TSHZ3 DNA-binding domain can test its repressive function on differentiation timing.
Knock-in
CRISPR knock-in of fluorescent reporters (e.g., GFP) or epitope tags into endogenous loci such as CAV3 or ACTA2 allows real-time monitoring of smooth muscle differentiation in live cells and tissues. Tagged knock-in of MYOCD enables chromatin immunoprecipitation (ChIP) to identify its target genes during positive regulation. Knock-in of lineage-tracing cassettes (e.g., CreERT2) into WNT4 can trace progenitor contribution to ureter smooth muscle.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can ectopically express positive regulators such as MYOCD or SRF to test whether they are sufficient to accelerate ureter smooth muscle differentiation. Overexpression of TSHZ3 or SOX9 can delay differentiation, confirming their inhibitory role. These gain-of-function models complement knockout studies to establish causality.
How EDITGENE Supports positive regulation of ureter smooth muscle cell differentiation Research
Researchers studying positive regulation of ureter smooth muscle cell differentiation-related genes often need to determine whether a candidate gene is causally involved in promoting or timing this process. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional validation of genes within GO:2000063.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of ureter smooth muscle cell differentiation research.
Frequently Asked Questions About positive regulation of ureter smooth muscle cell differentiation
What is GO:2000063?
GO:2000063 is the Gene Ontology term for positive regulation of ureter smooth muscle cell differentiation, defined as any process that activates or increases the frequency, rate or extent of ureter smooth muscle cell differentiation.
What genes are involved in positive regulation of ureter smooth muscle cell differentiation?
Key genes include MYOCD, SRF, TSHZ3, SOX9, and WNT4, which regulate the timing and extent of differentiation.
How is ureter smooth muscle cell differentiation regulated?
It is regulated by a balance between pro-differentiation factors like myocardin and inhibitory factors like TSHZ3 and SOX9, which modulate myocardin activity.
What diseases are associated with defects in ureter smooth muscle differentiation?
Congenital obstructive uropathy, hydronephrosis, and ureteral motility disorders are associated with impaired differentiation.
What methods are used to study positive regulation of ureter smooth muscle cell differentiation?
Common methods include RNA-seq, single-cell RNA-seq, proteomics, immunofluorescence, lineage tracing, and ex vivo peristalsis assays.
Can CRISPR be used to study this process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can test the role of specific genes in ureter smooth muscle differentiation.
What is the role of TSHZ3 in ureter smooth muscle differentiation?
TSHZ3 acts as a negative regulator that delays differentiation by reducing myocardin activity; its inhibition promotes differentiation.
What is the role of SOX9 in ureter smooth muscle differentiation?
SOX9 similarly delays differentiation by reducing myocardin activity, and its downregulation is associated with positive regulation.
How do Wnt4-expressing cells contribute to ureter smooth muscle?
Wnt4-expressing progenitors in the developing kidney contribute to the smooth muscle lineage of the ureter.
What are markers of ureter smooth muscle differentiation?
Markers include alpha-smooth muscle actin (ACTA2), caveolin-3 (CAV3), transgelin (TAGLN), and smooth muscle myosin heavy chain (MYH11).
Conclusion
GO:2000063, positive regulation of ureter smooth muscle cell differentiation, is a critical biological process that ensures proper development and function of the urinary tract. The interplay between pro-differentiation factors such as myocardin and inhibitory regulators like TSHZ3 and SOX9 controls the timing of differentiation, while lineage contributions from Wnt4-expressing progenitors provide the cellular source. Defects in this process are linked to congenital obstructive uropathies and motility disorders, underscoring its clinical relevance. Researchers can leverage CRISPR-based models, including knockout, point mutation, knock-in, and overexpression, to dissect the molecular mechanisms of this process. EDITGENE offers comprehensive services to support such studies, from custom cell line generation to library screening and bioinformatics, empowering discoveries that may lead to new therapeutic strategies for urinary tract diseases.
References
- 1. Martin E et al.. 2013. TSHZ3 and SOX9 regulate the timing of smooth muscle cell differentiation in the ureter by reducing myocardin activity.. PLoS One 8(5):e63721 PMID: 23671695
- 2. Baker LA et al.. 1998. Embryonic development of the ureter and bladder: acquisition of smooth muscle.. J Urol 160(2):545-50 PMID: 9679926
- 3. Namba T et al.. 2024. Collagen 17A1 in the Urothelium Regulates Epithelial Cell Integrity and Local Immunologic Responses in Obstructive Uropathy.. Am J Pathol 194(8):1550-1570 PMID: 38768778
- 4. Kogo H et al.. 2006. Differential expression of caveolin-3 in mouse smooth muscle cells in vivo.. Cell Tissue Res 324(2):291-300 PMID: 16609918
- 5. Shan J et al.. 2010. Mapping of the fate of cell lineages generated from cells that express the Wnt4 gene by time-lapse during kidney development.. Differentiation 79(1):57-64 PMID: 19740593
- 6. Gladkiĭ AP. 1975. [Some regularities of the regeneration of the musculature of internal organs].. Arkh Anat Gistol Embriol 69(8):101-9 PMID: 126673
- 7. Metzger R et al.. 2004. Cajal-like cells in the human upper urinary tract.. J Urol 172(2):769-72 PMID: 15247779
- 8. Velagapudi C et al.. 2012. Reciprocal induction of simple organogenesis by mouse kidney progenitor cells in three-dimensional co-culture.. Am J Pathol 180(2):819-30 PMID: 22138298
